Navigation Links
23 researchers join network of EMBO Young Investigators
Date:11/6/2013

HEIDELBERG, 6 NOVEMBER 2013 EMBO announced today the selection of 23 young researchers as EMBO Young Investigators. The scientists join a network of 315 current and past Young Investigators.

The Young Investigator Programme is for researchers under forty years of age who have established their first laboratories in the past four years. The successful candidates work in ten European countries, Israel and Singapore. The success rate for selection to this highly competitive programme was twelve per cent this year.

"The newly elected EMBO Young Investigators have the potential to be tomorrow's life science leaders," says Gerlind Wallon, EMBO Deputy Director and Manager of the Young Investigator Programme. "The status of Young Investigator offers a level of recognition that brings immediate benefits to scientists at an early stage of their careers."

Financial support includes 15,000 euros per year for three years directly from the member state where the laboratories of the scientists are located. The researchers receive a range of benefits to help start their first independent research laboratories. Laboratory management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. The scientists also receive access to core facilities at EMBL and funding for themselves and their group members to attend conferences.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1

Related biology news :

1. Breakthrough by Temple researchers could lead to new treatment for heart attack
2. Temple researchers uncover clues to how existing heart drugs work
3. Researchers unmask centuries-old elephant imposter
4. Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
5. Penn researchers identify molecular link between gut microbes and intestinal health
6. Researchers Able to Identify that Benign Tumors from Use of Oral Contraceptive Have a Greater Chance of Becoming Malignant
7. Children of lower socioeconomic status grow up more susceptible to catching colds, Carnegie Mellon researchers find
8. University of Louisville researchers sign global licensing agreement
9. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
10. Researchers quantify toxic ocean conditions during major extinction 93.9 million years ago
11. Researchers discover how cancer invisibility cloak works
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/9/2017)... -- The biomass boiler market report by Transparency Market ... globally in terms of revenue (US$ Mn) based on ... biomass boilers has been segmented on the basis of ... market based on feedstock type, has been segmented into ... crops, urban residues, and others. On the basis of ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... 22, 2017  UBM and the Massachusetts Medical ... extended partnership and the third annual Massachusetts Medtech Week. ... 21 st Annual MassMEDIC Conference held in ... 3-4, 2017. MassMEDIC will feature ... President and CEO, Scott Whitaker , at ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
Breaking Biology Technology: